ArticleMedical hypotheses2018
mTOR inhibitors for treatment of low-risk prostate cancer.
Michael A Liss et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleMedical hypotheses2018
Michael A Liss et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.